Insulin Regulation of Lysine and α-Aminoadipic Acid Dynamics and Amino Metabolites in Women With and Without Insulin Resistance
Diabetes · 2024
DOI: 10.2337/db23-0977 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2024. Verfasst von Alice Y Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL. Hauptthemen laut MEDLINE: Insulin Resistance, Lysine, Insulin, 2-Aminoadipic Acid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Mayo Foundation for Medical Education and Research, NIDDK NIH HHS.
Abstract (Originalsprache)
Insulin is a key regulator of amino acid metabolism. Many plasma amino acids, including lysine and its metabolite, α-aminoadipic acid (α-AA), a predictor for developing diabetes, are elevated in insulin resistance (IR). In 18 overweight women with IR and polycystic ovary syndrome compared with 12 lean control women, high physiological insulin during a euglycemic clamp failed to normalize many elevated amino acid metabolites, including branched-chain and aromatic amino acids, α-aminobutyric acid, and lysine, but normalized α-AA. To understand the underpinnings of differential responses of lysine and its metabolic product α-AA to high physiological insulin in IR compared with control participants, we developed a kinetic model using [α-15N1]-lysine and [13C1]-α-AA as tracers and measured the two tracers simultaneously in α-AA by innovative mass spectrometry. High insulin increased lysine conversion to α-AA in the IR and control groups but failed to normalize plasma lysine concentrations in IR due to a decrease in lysine metabolic clearance rate (MCR). In contrast, despite higher conversion rates of lysine to α-AA by high insulin, α-AA concentration decreased in IR because of the sustained greater MCR of α-AA. The abnormal amino acids and metabolites, even while on high physiological insulin, could potentially explain many functional derangements in IR. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL.
- Division of Endocrinology, Diabetes, and Nutrition, Mayo Clinic College of Medicine, Rochester, MN.
- Mayo Clinic Metabolomics Core, Mayo Clinic College of Medicine, Rochester, MN.
ORCID-Profile: K Sreekumaran Nair
Förderung
- NICHD NIH HHS
- Mayo Foundation for Medical Education and Research
- NIDDK NIH HHS
- CSR NIH HHS
- NIA NIH HHS
- NCATS NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Advancing Translational Sciences
Zitieren
APA
Chang, A. Y., Asokan, A. K., Lalia, A. Z., Sakrikar, D., Lanza, I. R., Petterson, X. M., & Nair, K. S. (2024). Insulin Regulation of Lysine and α-Aminoadipic Acid Dynamics and Amino Metabolites in Women With and Without Insulin Resistance. Diabetes. https://doi.org/10.2337/db23-0977
Vancouver
Chang AY, Asokan AK, Lalia AZ, Sakrikar D, Lanza IR, Petterson XM, et al. Insulin Regulation of Lysine and α-Aminoadipic Acid Dynamics and Amino Metabolites in Women With and Without Insulin Resistance. Diabetes. 2024. doi:10.2337/db23-0977
BibTeX
@article{Chang2024,
author = {Chang, Alice Y and Asokan, Aneesh K and Lalia, Antigoni Z and Sakrikar, Dhananjay and Lanza, Ian R and Petterson, Xuan-Mai and Nair, K Sreekumaran},
title = {Insulin Regulation of Lysine and α-Aminoadipic Acid Dynamics and Amino Metabolites in Women With and Without Insulin Resistance},
journal = {Diabetes},
year = {2024},
doi = {10.2337/db23-0977}
}
EUVIMED